PT  - JOURNAL ARTICLE
AU  - Billy J Quilty
AU  - Samuel Clifford
AU  - Stefan Flasche
AU  - Adam J Kucharski
AU  - CMMID COVID-19 Working Group
AU  - W John Edmunds
TI  - Quarantine and testing strategies in contact tracing for SARS-CoV-2: a modelling study
AID  - 10.1101/2020.08.21.20177808
DP  - 2020 Jan 01
TA  - medRxiv
PG  - 2020.08.21.20177808
4099  - http://medrxiv.org/content/early/2020/10/23/2020.08.21.20177808.short
4100  - http://medrxiv.org/content/early/2020/10/23/2020.08.21.20177808.full
AB  - Background In most countries, contacts of confirmed COVID-19 cases are asked to quarantine for 14 days following exposure, to limit asymptomatic onward transmission. We assessed the merit of RT-PCR testing in reducing the length of quarantine, using the UK as a case study.Methods We used an agent-based model to simulate an exposed contact’s contact tracing detecting delay, incubation period, probability to become symptomatic, infectivity profile, and time-varying PCR detection probability. Assuming self-isolation on symptom onset, we assess the impact of the current 14 day quarantine strategy for all exposed contacts on their onward transmission potential and compare to alternative quarantine lengths with or without PCR tests during quarantine.Findings Self-isolation on symptoms onset alone can prevent 39% (95% Uncertainty Interval for super spreading events: 34, 45%) of onward transmission from secondary cases. An additional 14 days post-exposure quarantine for all contacts reduces transmission by 70% (95% UI: 39, 90%). A negative PCR test taken upon tracing or 7 days after exposure can reduce transmission by 62% (95% UI: 40, 84%) or 68% (95% UI: 40, 88%) respectively. Halving contact tracing delays of currently 4 days reduces pre-tracing transmission potential from 26% (95% UI: 7, 56%) to 14% (95% UI: 5, 42%).Interpretation PCR testing may allow for a substantial reduction in quarantine needs or even replacing quarantine requirements with no or a small excess in transmission risk respectively. Reducing contact tracing delays can help prevent a substantial amount of transmission.Funding National Institute for Health Research, UK Research and Innovation, Wellcome Trust, and EU Horizon 2020.Evidence before this study During the SARS-CoV-2 pandemic, a standard 14-day quarantine period has been required from the day a contact was exposed to an index case to avert onwards transmission. This approach aims to avoid infected contacts returning to their normal life during their pre-symptomatic period. This strategy presents a crucial part in the global pandemic response to interrupt transmission chains, however it places considerable social and economic pressure on contacts. As case numbers are rapidly rising across Europe an effective, practical and widely accepted strategy to limit secondary transmission is key to the control of SARS-CoV-2. To the best of our knowledge, this is the first analysis of optimal strategies to reduce transmission from contact traced secondary cases.Added value of this study We simulated the ability of different quarantine and testing strategies to reduce the transmission potential of secondary cases. We found that the common post-exposure quarantine period of 14 days is equally effective as PCR testing of contacts after 7 days of quarantine. PCR testing immediately on tracing with no quarantine requirements following a negative test result would avert slightly less transmission potential from secondary cases (62% vs 70%). Delays in identifying contacts and hence delayed quarantine as well as low adherence substantially reduces the ability to reduce secondary transmission.Implications of all the available evidence The ability to test timely and at scale could shorten current delays in contact tracing and thereby reduce the risk for secondary transmission. Similarly, such testing capacity would allow to substantially shorten necessary quarantine periods and dampen the economic and social impact while potentially increasing compliance.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis research was partly funded by the National Institute for Health Research (NIHR) (Billy Quilty is funded by 16/137/109 & 16/136/46) using UK aid from the UK Government to support global health research. The views expressed in this publication are those of the author(s) and not necessarily those of the NIHR or the UK Department of Health and Social Care. This research has been funded by UK Research and Innovation - MC_PC_19065 - Covid 19: Understanding the dynamics and drivers of the COVID-19 epidemic using real-time outbreak analytics (Samuel Clifford, W John Edmunds). This research was partly funded by the Wellcome Trust (Sir Henry Dale Fellowship: 208812/Z/17/Z, Stefan Flasche and Samuel Clifford; 206250/Z/17/Z, Adam J Kucharski). This project has received funding from the European Union's Horizon 2020 research and innovation programme - project EpiPose (W John Edmunds). The authors declare no conflicts of interest.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The data used for this modelling work is provided to the public by the UK Department of Health and Social Care from the NHS' Test and Trace programme.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesModel code is available at https://github.com/cmmid/pcr_track_trace https://github.com/cmmid/pcr_track_trace